Medicare deadline for LVADs
This article was originally published in The Gray Sheet
July 14 due date is set for the Medicare Coverage Advisory Committee's final decision on coverage of left ventricular assist devices as destination therapy (1"The Gray Sheet" March 17, 2003, p. 16). 2Minutes and a transcript for the March 12 MCAC meeting are now available...
You may also be interested in...
The cost-effectiveness of new therapies should be considered by CMS during the Medicare coverage process, according to some members of the Medicare Coverage Advisory Committee
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.